Cyclerion Therapeutics, Inc.CYCNNASDAQ
Loading
Price to Sales: Discounted ValuationCompressed
Percentile Rank50
3Y CAGR-41.5%
5Y CAGR-24.5%
Year-over-Year Change
Price-to-sales ratio
3Y CAGR
-41.5%/yr
Annual compound
5Y CAGR
-24.5%/yr
Recent deceleration
Percentile
P50
Within normal range
vs 5Y Ago
0.2x
Contraction
Streak
1 yr
Consecutive growthCompressed
| Period | Value | YoY Change |
|---|---|---|
| 2024 | 4.05 | - |
| 2023 | 0.00 | -100.0% |
| 2022 | 95.99 | +373.3% |
| 2021 | 20.28 | -50.0% |
| 2020 | 40.52 | +145.2% |
| 2019 | 16.52 | - |
| 2018 | 0.00 | - |
| 2017 | 0.00 | - |
| 2016 | 0.00 | - |